🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for female reproductive organ cancer

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. NCT06481592Phase 212 sites📍 Phoenix📍 Los Angeles📍 Orlando Iovance Biotherapeutics, Inc. · Tests: Lifileucel ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients NCT06844136n/a1 site📍 Liverpool Pierian Biosciences · Tests: No intervention Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy NCT07361471NA1 site📍 Clermont-Ferrand Centre Jean Perrin · Tests: molecular analysis Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix NCT04723095n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Follow-Up, Medical Chart Review Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer NCT07643012NA1 site📍 New Brunswick Rutgers, The State University of New Jersey · Tests: MR-guided adaptive pelvic intensity-modulated radiation therapy (IMRT) Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking NCT05977621n/a1 site📍 Durham Duke University · Tests: Transrectal ultrasound (TRUS) The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103) NCT04555226NA1 site📍 Chongqing Chongqing University Cancer Hospital · Tests: Lymph node dissection, Standard chemoradiation±pembrolizumab, Chemoradiation± pembrolizumab Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC) NCT07055399Phase 21 site📍 Fuzhou Fujian Cancer Hospital · Tests: neoadjuvant chemo-immunotherapy: Iparomlimab and tuvonralimab plus cisplatin,nab-paclitaxel for 1 cycle and Iparomlimab… Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer NCT06656949NA1 site📍 Jinan Qilu Hospital of Shandong University · Tests: injecting indocyanine green (ICG) dye Intraoperative Setting Up ctDNA Analysis on Archived Plasma Samples NCT07546578n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: ctDNA MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women with Complex Pelvic Adnexal Masses ≤ 8cm. NCT06638593NA1 site📍 Guildford Royal Surrey County Hospital NHS Foundation Trust · Tests: MIRRORS-FROZEN Protocol., Standard open surgery GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer NCT07489287Phase 11 site📍 Buffalo Roswell Park Cancer Institute · Tests: GB-5267 - IV only, GB-5267 -Combined IV and IP Infusion Combination Therapy for Recurrent Ovarian Cancer NCT05610735Phase 1, Phase 21 site📍 Louisville Sham Sunder Kakar · Tests: DOXIL, Withaferin A, Ashwagandha, Combination of ASWD and DOXIL MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer NCT06483048Phase 11 site📍 Scottsdale Mayo Clinic · Tests: Autologous MUC1-activated T-cells, Bendamustine, Biospecimen Collection, Computed Tomography, Cyclophosphamide Trop2-targeted immunoPET Imaging of Solid Tumors NCT06851663Phase 2, Phase 31 site📍 Shanghai RenJi Hospital · Tests: [68Ga]Ga-NOTA-T4, [68Ga]Ga-NOTA-RT4, [18F]F-RESCA-T4, [18F]F-RESCA-RT4 Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer NCT06019923n/a1 site📍 Hangzhou Women's Hospital School Of Medicine Zhejiang University · Tests: No intervention A Cohort Study of Uterine Malignancies NCT05635123n/a1 site📍 Hangzhou Women's Hospital School Of Medicine Zhejiang University · Tests: No intervention The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women NCT06556342NA1 site📍 Wuhan Tongji Hospital · Tests: FRD001 Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy NCT07662824NA1 site📍 Rochester Mayo Clinic · Tests: Educational Intervention, Interview, Flyte Medical Device Usage and Evaluation, Questionnaire Administration, Referral Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer NCT05647109n/a1 site📍 Beijing Peking University People's Hospital · Tests: No intervention Effect of Orlistat on Metabolic and Hormonal Features in Women With Polycystic Ovary Syndrome (PCOS): a Randomized Controlled Clinical Trial NCT07747909NA1 site📍 Abbottābād Khyber Medical University Peshawar · Tests: Orlistat, Placebo, Standard Lifestyle Advice DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome NCT03911297n/a1 site📍 Birmingham Imperial College London · Tests: Women with polycystic ovary syndrome A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762Phase 162 sites📍 Birmingham📍 Birmingham📍 Birmingham Seagen, a wholly owned subsidiary of Pfizer · Tests: PF-08046054, pembrolizumab OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial Cancer NCT06935305NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: OSNA, Ultrastaging 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors NCT07760012NA1 site📍 Beijing Peking University Third Hospital · Tests: 68Ga-SorB PET/CT A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients NCT06522828Phase 21 site📍 Chongqing Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Tests: SSGJ-707, carboplatin, paclitaxel CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer NCT06584032Phase 317 sites📍 Beijing📍 Chongqing📍 Fuzhou Hutchmed · Tests: fruquintinib, sintilimab, paclitaxel, doxorubicin Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites📍 Scottsdale📍 La Jolla📍 Stanford BioEclipse Therapeutics · Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer NCT06893861n/a1 site📍 Naples National Cancer Institute, Naples · Tests: Metabolomic profiling
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy